TAO Synergies TAOX
NASDAQ TAOX
$4.14 +0.13 (+3.10%)
As of: Sep 9, 2026 · 1:19 PM EDT

TAO Synergies (TAOX) Total Current Liabilities (2019 - 2026)

TAO Synergies' (TAOX) quarterly Total Current Liabilities came in at $1.0 million in Q2 2026, up 6.99% on a YoY basis from $964257.0 in Q2 2025, and down 6.53% quarter-over-quarter from $1.1 million in Q1 2026.

Analysis

TAO Synergies (TAOX) Total Current Liabilities (2019 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Total Current Liabilities for 8 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Current Liabilities rose 6.99% year-over-year to $1.0 million; the trailing twelve-month figure through Jun 2026 stood at $1.0 million (up 6.99% YoY), and the FY2025 full-year result was $1.8 million, up 78.83% from the prior year.
  • Total Current Liabilities slipped to $1.0 million in Q2 2026 per TAOX's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $9.4 million in Q2 2024 and bottomed at $210665.0 in Q1 2025.
  • Historically, Total Current Liabilities has averaged $2.0 million across 5 years, with a median of $1.1 million in 2025.
  • The sharpest annual moves came in 2025 and 2026: Total Current Liabilities plunged 96.66% in 2025, then surged 423.93% in 2026.
  • Over 5 years, Total Current Liabilities stood at $1.3 million in 2022, then jumped by 225.75% to $4.3 million in 2023, then plunged by 76.28% to $1.0 million in 2024, then surged by 78.83% to $1.8 million in 2025, then slumped by 43.13% to $1.0 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $1.0 million, $1.1 million, and $1.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Amgen 211.51 Bn 197.52 Bn 7.24 Bn 25.50 Bn
2 Gilead Sciences 181.48 Bn 178.30 Bn 6.22 Bn 11.02 Bn
3 Vertex Pharmaceuticals 132.45 Bn 124.60 Bn 2.84 Bn 3.94 Bn
4 Regeneron Pharmaceuticals 82.87 Bn 74.88 Bn 3.93 Bn 5.53 Bn
5 Argenx Se 61.59 Bn 56.41 Bn 1.37 Bn 1.58 Bn
6 Moderna 54.72 Bn 49.59 Bn 52.00 Mn 2.53 Bn
7 Alnylam Pharmaceuticals 34.13 Bn 30.82 Bn 992.69 Mn 1.51 Bn
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn 3.92 Bn
9 Roivant Sciences 30.31 Bn 30.31 Bn 1.16 Mn 283.60 Mn
10 TAO Synergies 30.90 Mn 30.90 Mn - 1.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.03 Mn
Mar 31, 2026 1.10 Mn
Dec 31, 2025 1.81 Mn
Sep 30, 2025 1.04 Mn
Jun 30, 2025 964,257.00
Mar 31, 2025 210,665.00
Dec 31, 2024 1.01 Mn
Sep 30, 2024 340,892.00
Jun 30, 2024 9.35 Mn
Mar 31, 2024 6.30 Mn
Dec 31, 2023 4.28 Mn
Sep 30, 2023 1.82 Mn
Jun 30, 2023 2.77 Mn
Mar 31, 2023 1.28 Mn
Dec 31, 2022 1.31 Mn
Sep 30, 2022 683,595.00
Jun 30, 2022 625,979.00
Mar 31, 2022 669,338.00
Dec 31, 2021 1.99 Mn
Sep 30, 2021 1.01 Mn